A comparative analysis of 23 structures of the amyloidogenic protein transthyretin

被引:181
作者
Hörnberg, A
Eneqvist, T
Olofsson, A
Lundgren, E
Sauer-Eriksson, AE [1 ]
机构
[1] Umea Univ, Umea Ctr Mol Pathogenesis, S-90187 Umea, Sweden
[2] Umea Univ, Dept Cell & Mol Biol, S-90187 Umea, Sweden
关键词
transthyretin; amyloidosis; X-ray structure; structural comparison; familial amyloidotic polyneuropathy;
D O I
10.1006/jmbi.2000.4078
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Self-assembly of the human plasma protein transthyretin (TTR) into unbranched insoluble amyloid fibrils occurs as a result of point mutations that destabilize the molecule, leading to conformational changes. The tertiary structure of native soluble TTR and many of its disease-causing mutants have been determined. Several independent studies by X-ray crystallography have suggested structural differences between TTR variants which are claimed to be of significance for amyloid formation. As these changes are minor and not consistent between the studies, we have compared all TTR structures available at the protein data bank including three wild-types, three non-amyloidogenic mutants, seven amyloidogenic mutants and nine complexes. The reference for this study is a new 1.5 Angstrom resolution structure of human wild-type TTR refined to an R-factor/R-free of 18.6%/21.6%. The present findings are discussed in the light of the previous structural studies of TTR variants, and show the reported structural differences to be non-significant. (C) 2000 Academic Press.
引用
收藏
页码:649 / 669
页数:21
相关论文
共 86 条
[61]  
PUCHTLER H, 1985, Applied Pathology, V3, P5
[62]   The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution [J].
Quintas, A ;
Saraiva, MJM ;
Brito, RMM .
FEBS LETTERS, 1997, 418 (03) :297-300
[63]  
Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7
[64]   A simple method for making reproducible fibre loops for protein cryocrystallography [J].
Sauer, UH ;
Ceska, TA .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1997, 30 :71-72
[65]   Tertiary structures of amyloidogenic and non-amyloidogenic transthyretin variants: new model for amyloid fibril formation [J].
Schormann, N ;
Murrell, JR ;
Benson, MD .
AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1998, 5 (03) :175-187
[66]   The evolution of gene expression, structure and function of transthyretin [J].
Schreiber, G ;
Richardson, SJ .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY, 1997, 116 (02) :137-160
[67]   The crystal structure of amyloidogenic Leu55 → Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils [J].
Sebastiao, MP ;
Saraiva, MJ ;
Damas, AM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (38) :24715-24722
[68]   Crystallization and preliminary X-ray diffraction studies of Leu55Pro variant transthyretin [J].
Sebastiao, P ;
Dauter, Z ;
Saraiva, MJ ;
Damas, AM .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1996, 52 :566-568
[69]   AMYLOIDOSIS [J].
SIPE, JD .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1994, 31 (04) :325-354
[70]   AMYLOIDOSIS [J].
SIPE, JD .
ANNUAL REVIEW OF BIOCHEMISTRY, 1992, 61 :947-975